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Abstract
Background
Two platyhelminths of biomedical and commercial significance are Schistosoma mansoni
(blood fluke) and Fasciola hepatica (liver fluke). These related trematodes are responsible
for the chronic neglected tropical diseases schistosomiasis and fascioliasis, respectively.
As no vaccine is currently available for anti-flukicidal immunoprophylaxis, current treatment
is mediated by mono-chemical chemotherapy in the form of mass drug administration
(MDA) (praziquantel for schistosomiasis) or drenching (triclabendazole for fascioliasis) pro-
grammes. This overreliance on single chemotherapeutic classes has dramatically limited
the number of novel chemical entities entering anthelmintic drug discovery pipelines, raising
significant concerns for the future of sustainable blood and liver fluke control.
Methodology/ Principle Findings
Here we demonstrate that 7-keto-sempervirol, a diterpenoid isolated from Lycium chinense,
has dual anthelmintic activity against related S.mansoni and F. hepatica trematodes. Using
a microtiter plate-based helminth fluorescent bioassay (HFB), this activity is specific (Thera-
peutic index = 4.2, when compared to HepG2 cell lines) and moderately potent (LD50 = 19.1
μM) against S.mansoni schistosomula cultured in vitro. This anti-schistosomula effect
translates into activity against both adult male and female schistosomes cultured in vitro
where 7-keto-sempervirol negatively affects motility/behaviour, surface architecture (induc-
ing tegumental holes, tubercle swelling and spine loss/shortening), oviposition rates and
egg morphology. As assessed by the HFB and microscopic phenotypic scoring matrices,
7-keto-sempervirol also effectively kills in vitro cultured F. hepatica newly excysted juveniles
(NEJs, LD50 = 17.7 μM). Scanning electron microscopy (SEM) evaluation of adult F. hepati-
ca liver flukes co-cultured in vitro with 7-keto-sempervirol additionally demonstrates pheno-
typic abnormalities including breaches in tegumental integrity and spine loss.
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Conclusions/ Significance
7-keto-sempervirol negatively affects the viability and phenotype of two related pathogenic
trematodes responsible for significant human and animal infectious diseases. This plant-
derived, natural product is also active against both larval and adult developmental forms. As
such, the data collectively indicate that 7-keto-sempervirol is an important starting point for
anthelmintic drug development. Medicinal chemistry optimisation of more potent 7-keto-
sempervirol analogues could lead to the identification of novel chemical entities useful for
future combinatorial or replacement anthelmintic control.
Author Summary
Schistosomiasis and fascioliasis are caused by two related trematodes found within the
phylum Platyhelminthes (flatworms), and are classified as neglected diseases of poverty
due to their effects on people living in the most underprivileged areas of the world. With
no vaccine currently near development, and the existing strategy for global control based
on the over-reliance on single-class chemotherapies, there is an urgent requirement for the
identification of next generation anthelmintics. Here we demonstrate that 7-keto-semper-
virol, a natural product derived from Lycium chinense, displays dual anthelmintic activity
towards both Schistosoma mansoni (causative agent of schistosomiasis) and Fasciola he-
patica (causative agent of fascioliasis). Utilising objective and phenotypic matrices, we
show this activity to be selective (compared to a human cell line) and moderately potent
against S.mansoni and F. hepatica larvae. This anti-larval effect translates into additional
activity against both S.mansoni and F. hepatica adults where 7-keto-sempervirol induces
phenotypic abnormalities including tegumental damage, motility disruption and oviposi-
tion inhibition. Due to 7-keto-sempervirol’s anthelmintic activity against multiple life
stages of two parasitic trematodes, we contend that this starting chemical scaffold could be
used to develop more effective compounds useful in controlling important parasites of bio-
medical and commercial relevance.
Introduction
Schistosomiasis and fascioliasis are Neglected Tropical Diseases (NTDs) caused by related par-
asitic blood (Schistosoma sp. including Schistosoma mansoni) and liver (Fasciola sp including
Fasciola hepatica) flukes found within the phylum Platyhelminthes. These NTDs are responsi-
ble for chronic conditions of biomedical and veterinary significance and collectively affect a
considerable proportion of the world’s human and animal populations. Globally, approximate-
ly 200 million people are currently afflicted by schistosomiasis, with this chronic disease being
most prominent in tropical/subtropical regions of poverty-stricken, rural areas [1]. While fasci-
oliasis is one of the most important parasitic diseases of ruminant livestock animals, it also neg-
atively impacts 2.4 to 17 million humans worldwide by inducing chronic liver pathologies in
infected individuals [2].
Control of these two NTDs remains largely centred on the use of large-scale chemotherapy
administered to infected individuals in high prevalence areas. Praziquantel (PZQ) is presently
the gold standard drug of choice for schistosomiasis control due to its safety, low cost, and ac-
tivity towards the adult life stage of the three major, human-infective species (S.mansoni,
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Schistosoma haematobium and Schistosoma japonicum) [3]. For fascioliasis chemotherapy, tri-
clabendazole (TCBZ) remains the drug of choice and is the only available compound effective
against both adult and juvenile liver fluke lifecycle stages [4]. In both cases, the over-reliance
on a single drug class for maintaining the future of blood and liver fluke control has generated
significant concerns that drug resistant flukes could eventually develop (Schistosoma) or in-
crease in prevalence (Fasciola). Although potential new replacement or combinatorial anthel-
mintic compounds have recently been identified [5–11], concerns have been raised regarding
the insufficient activity in this research area due to the perceived sustainability of current op-
tions [12,13].
Moving forward, it is becoming evident that a relatively untapped source of chemical enti-
ties for developing new anthelmintics is plants and their natural products [14–16]. Plants pos-
sess a diverse arsenal of chemical reserves that have evolved to aid in plant protection and
competition, and this has been exploited for medicinal uses for centuries [17]. For example,
while artemisinin (derived from Artemisia annua) and derivatives represent the current, front-
line anti-malarials [18], they also display significant activity against Schistosoma and Fasciola
[7,19]. Further interrogation of the chemical diversity found in plants suggests that terpenoids
(terpenes) are the most abundant and numerous of the plant secondary products and they pos-
sess features, including considerable structural variation [20], that may be exploitable as next-
generation anthelmintics. In clear support of this, previous studies have demonstrated that top-
ical terpenoid application to the skin effectively prevents schistosome penetration, providing
an innovative chemoprophylactic method to avert schistosomiasis [21,22]. However, it is pres-
ently unclear how terpenoids affect schistosome biology or, indeed, if they have activity against
other parasitic trematodes, including F. hepatica, due to lack of detailed investigations.
In this study a diterpenoid (7-keto-sempervirol) extracted and purified from Lycium chi-
nense (common name Wolfberry), a plant traditionally used in Asian medicine since 1000 AD
[23], was thoroughly investigated for its anthelmintic properties against S.mansoni and
F. hepatica larvae and adults. Here, we demonstrate that 7-keto-sempervirol selectively kills lar-
val stages of each trematode and induces tegumental damage, as well as motility disruption, in
both hermaphroditic and dioecious adults. Furthermore, 7-keto-sempervirol dramatically in-
hibits the developmental maturation and oviposition of phenotypically normal S.mansoni
eggs. Collectively these findings suggest that diterpenoids, such as 7-keto-sempervirol, have
broad activities against related trematodes and should be further investigated as starting points
for combating both schistosomiasis and fascioliasis.
Methods
Ethics statement
All procedures performed on mice adhered to the United Kingdom Home Office Animals (Sci-
entific Procedures) Act of 1986 (project license PPL 40/3700) as well as the European Union
Animals Directive 2010/63/EU and were approved by Aberystwyth University’s (AU) Animal
Welfare and Ethical Review Body (AWERB).
Compound storage and handling
The diterpenoid 7-keto-sempervirol was isolated from the root of the temperate plant Lycium
chinense (The Organic Herb Trading Company, Milverton, UK). Two kilograms of ground
material was extracted in CH2Cl2 using a Soxhlet system. Nine fractions were obtained using
Biotage 75 flash chromatography (silica gel, eluted with a step gradient of increasing polarity:
n-hexane—ethylacetate—methanol). 7-keto-sempervirol was isolated from these fractions via
reverse-phase preparative HPLC (C18 preparative column, eluted with a gradient- water:
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acetonitrile: 0.1% trifluroacetic acid in acetonitrile, with UV detection). The compound struc-
ture was then determined by UV, 1H NMR, 13C NMR and LC-MS analyses and also through
direct comparison with the literature. The compound auranofin (Sigma-Aldrich, UK), a thiore-
doxin glutathione reductase (TGR) inhibitor capable of killing schistosomes, was used at
70 μM (final concentration) [24] as a dead control for the Helminth Fluorescent Bioassay
(HFB) [25]. Both compounds (auranofin and 7-keto-sempervirol) were stored at -80°C in
DMSO until use.
Schistosoma mansoni schistosomula culture
S.mansoni (NRMI strain) cercariae were shed from infected Biomphalaria glabrata snails
(NMRI strain) by exposure to 2 hours of light in an artificially heated room (26°C). Collected
cercariae were mechanically transformed into schistosomula as previously described [26] and
resuspended in culture media comprising DMEM (Dulbecco’s Modified Eagle Medium,
Sigma-Aldrich, UK) lacking phenol red, but containing 4.5 g/l glucose, 2 mM L-glutamine,
200 U/ml penicillin and 200 μg/ml streptomycin (all Sigma-Aldrich, UK). Schistosomula were
then transferred to a black sided, flat-bottom (optically clear) 96-well microtiter plate (Star
Lab, UK) at a density of 1000 parasites per 100 μl well. The plate was then incubated at 37°C
and 5% CO2 for 24 hr to allow parasite equilibration.
Adult Schistosoma mansoni culture
S.mansoni adult parasites were recovered by hepatic portal perfusion from Tuck Ordinary
mice (Harlan Laboratories, UK) experimentally infected seven weeks earlier with 200 cercariae.
Washed adult worms were cultured in DMEM containing phenol red, 4.5 g/l glucose, supple-
mented with 10% foetal calf serum, 2 mM L-glutamine, 200 U/ml penicillin, 200 μg/ml strepto-
mycin (all Sigma-Aldrich, UK). Schistosome cultures were maintained at 37°C in a humidified
atmosphere containing 5% CO2 for 24 hr prior to further manipulations. For egg laying experi-
ments, five adult worm pairs per ml of culture medium (48-well tissue culture plates) were cul-
tivated as above for a total of 72 hr (in the presence/absence of 7-keto-sempervirol). Eggs were
counted after 72 hr and classified as normal (oval and containing a fully-formed lateral spine)
or abnormal (lacking an oval shape and fully formed lateral spine).
Fasciola hepatica newly excysted juvenile (NEJ) culture
F. hepaticametacercariae (Baldwin Aquatic, Inc., OR, USA) were transformed into newly
excysted juveniles (NEJs) and equilibrated for 4 hr in Fasciola saline according to established
methodologies [27]. After equilibration, NEJs were distributed into black sided, flat-bottom
(optically clear) 96-well microtiter plates (Star Lab) at a density of 100 parasites per 100 μL well
and cultured at 37°C in a humidified atmosphere containing 5% CO2 subject to
further treatments.
Adult Fasciola hepatica culture
F. hepatica adult flukes were recovered from sheep livers (Ridgeway Research, UK), washed
and cultured in media comprising DMEM (lacking phenol red) containing 4.5 g/l glucose
(Sigma, UK). This was supplemented with 2.2 mM Ca(C2H3O2)2, 2.7 mMMgSO4, 61 mM glu-
cose, 15 mMHEPES, 1 μM serotonin and 5 μg/ml gentamycin (all Sigma, UK). Adult fluke
were placed in 12-well tissue culture plates, 1 parasite per well in 1 ml of culture media and cul-
tivated for 48 hr at 37°C in a humidified atmosphere containing 5% CO2.
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HepG2 cell culture and CellTitre-Glo assay
The human HepG2 cell line purchased from the European collection of cell cultures (ECACC
85011430) was grown to confluency in culture media comprising EMEM (Eagle’s Minimum
Essential Medium) supplemented with 10% bovine calf serum, 2 mM L-glutamine, 1% non-
essential amino acid solution (all Sigma Aldrich, UK) and 100 U/ml penicillin and 100 μg/ml
streptomycin (Invitrogen, UK). Cells were resuspended by trypsinisation (0.25% v/v for 5
min), rinsed and distributed into black sided, flat-bottom (optically clear) 96-well microtiter
plates (StarLab, UK) at 50 μl/well (1x105 cells/ well). The plate was equilibrated in a humidified
atmosphere containing 5% CO2 at 37°C for 2 hrs and then test compounds were added to rele-
vant wells to create a total well volume of 100 μl/well. Live controls included cells incubated in
the same concentration (1% v/v) of DMSO that was used in the experimental (compound treat-
ed) wells. Dead controls included cells incubated with 1% v/v Triton X-100 (Sigma-Aldrich)
[28]. Tissue culture plates were returned to a humidified atmosphere containing 5% CO2 at
37°C for a further 24 hrs.
The CellTitre-Glo reagents were prepared according to the manufacturer’s instructions
(Promega, UK). Tissue culture plates were equilibrated to RT for 30 min before CellTitre-Glo
reagents were distributed into each plate well at 100 μl/well (total volume 200 μl/well) and
mixed on an orbital shaker for 2 min. Cells were then stabilised for 10 min at RT and bubbles
that may have formed were removed using a sterilised needle. After this time luminescent sig-
nal was read utilising the BMG Labtech Polarstar Omega Plate Reader and exported into
Microsoft Excel for further analysis and conversion into percentage viability.
Helminth Fluorescent Bioassay (HFB)
The HFB was utilised to objectively determine the viability of schistosomula and NEJ parasites
co-cultured in the presence of 7-keto-sempervirol, auranofin (70 μM) [8,29], DMSO (1% v/v)
or media only. HFB methodology applied to schistosomula was performed as previously de-
scribed [25] with a minor alteration. Here, as indicated in the schistosomula culture methods,
parasite viability was measured in the absence of foetal calf serum (FCS). A slight modification
of the HFB was also applied to NEJs and included assaying only 100 parasites/well (as opposed
to 1000 schistosomula/well). A total of 100 μl of test substance (varying concentrations) was
added to each well containing 100 μl of suspended parasites and cultured for 24 hr in a humidi-
fied atmosphere at 37°C before the HFB was performed.
Phenotypic measurements
The in vitro activity of 7-keto-sempervirol on S.mansoni adult worms and F. hepaticaNEJs
was assessed by measuring motility disturbances and morphological variations in comparison
to an appropriate live control (DMSO, 1% v/v). The scoring matrix used to assess S.mansoni
adult worm viability was based on the standard operating procedure for compound screening
at the Special Programme for Research and Training in Tropical Diseases, World Health Orga-
nization, WHO-TDR as previously described [30]. Motility was numerically scored from 0–4
with 0 being total absence of all motility, 1 indicating absence of motility other than gut peri-
stalsis, 2 representing minimal activity such as occasional head and tail movement, 3 demon-
strating slow activity and 4 signifying normal activity. Morphological descriptors of the
parasite were also recorded during phenotypic assessment and included ‘knots’ developing
along the normally cylindrical body line of the adult worms and the sloughing, blebbing or tu-
bercle swelling of the tegument. Scoring matrix assessment of the worms was performed at 24,
48 and 72 hr post treatment.
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NEJ phenotyping (a supportive metric of the HFB) was performed using values derived
from both movement indices and morphologic formats as previously described [31,32]. The
movement score ranges from 1–5 with 1 representing good/normal movement and 5 repre-
senting a complete absence of movement. The morphologic score ranges from 1–6 with 1 rep-
resenting a good/normal phenotype and 6 signifying a severely dissolved/granulated parasite.
This scoring matrix assessment (values derived from summation of both movement and mor-
phology metrics) was conducted at 24 hr post treatment.
Scanning electron, laser confocal scanning and high content imaging
microscopy
Prior to scanning electron microscopy (SEM) analysis, adult schistosomes and liver flukes were
first fixed in 2.5% (w/v) gluteraldehyde in phosphate buffered saline (PBS) for 24 hr at
22–24°C. After fixation, worms were washed 3 times in 1 X PBS, pH 7.5 and stored in the same
buffer at 4°C until use [33]. Fixed parasite material was subsequently washed twice in double
distilled water and dehydrated in ascending acetone percentages (30, 50, 70, 80, 90, 95, and
100%) for 15 minutes each as previously described [33,34]. Dehydrated worms were then criti-
cally dried (Polaron Critical Point Dryer E3000) for 1 hr in 100% acetone (critical point of CO2
is 7.38 MPa at a temperature of 31°C). Critically dried worms were mounted on aluminium
stubs, sputter coated with platinum/palladium and observed under a Hitachi S-4700 field emis-
sion scanning electron microscope [34].
For laser scanning confocal microscopy (LSCM), adult schistosomes were first fixed in a so-
lution containing 2% (v/v) acetic acid, 25% (v/v) formalin, 48% (v/v) ethanol and 25% (v/v)
H2O at room temperature for 24 hr. After fixation, worms were stained with Langeron’s Car-
mine as previously described [35]. Worms were then mounted on glass microscope slides in
DPX (distyrene, plasticiser, xylene) as previously described [36] and observed using a Leica
TCS SP5II laser scanning confocal microscope, equipped with a 40X oil immersion objective
and a 488 nm Argon laser and a 561nm DPSS laser.
S.mansoni eggs laid by adult females after 72 hr in vitro cultures (+/- 7-keto-sempervirol)
were fixed in a 10% formaldehyde solution to prepare the biological tissue for microscopy.
Fixed eggs were then phenotypically assessed by an ImageXpress micro XL High Content Im-
ager (Molecular Devices, UK). Fluorescent images were obtained using a FITC filter (40x mag-
nification). Schistosomula subjected to the HFB were visualised on the ImageXpress micro XL
High Content Imager using FITC (to identify fluorescein diacetate positive parasites) and
TRITC (to identify propidium iodide positive parasites) filters (10X magnification).
Statistical analysis
A One Way ANOVA was utilised to identify any significant differences between more than
three treatment groups followed by post hoc testing with the Tukey’s test to identify significant-
ly different means (means that do not share a letter are significantly different). Student’s t-test
was utilised to determine significant differences between two treatment groups.
Results
Anti-schistosomal 7-keto-sempervirol properties
Due to the previously described action of select terpenes on schistosome viability [21,22] and
definitive host penetration [37], we became interested in assessing the potential anthelmintic
activity of 7-keto-sempervirol, a diterpenoid purified from Lycium chinense (Fig. 1). Employing
the HFB [25], a titration series of 7-keto-sempervirol (100 μM–1.575 μM) was first used to
Anthelmintic Activity of 7-Keto-Sempervirol
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assess the ability of this diterpenoid to affect schistosomula viability during in vitro co-culture
(Fig. 2). At high 7-keto-sempervirol concentrations (100–25 μM), almost all of the schistoso-
mula were killed or severely affected as indicated by low percent viability values (Fig. 2A) and
fluorescent microscopic images of individual parasites (PI positive parasites> FDA positive
parasites) (Fig. 2B). Lower 7-keto-sempervirol concentrations (between 6.25 μM–1.575 μM)
had little effect on schistosomula viability and phenotype when compared to the DMSO con-
trol parasites. Based on these titration experiments, an LD50 of 19.1 μMwas derived for 7-keto-
sempervirol on the schistosomula lifecycle stage. A parallel set of titration experiments was ad-
ditionally performed with the human HepG2 cell line (S1 Fig.) and demonstrated a 7-keto-
sempervirol derived LD50 of 80 μM. 7-keto-sempervirol, therefore, demonstrates a therapeutic
index of 4.2 towards the intra-mammalian schistosomula lifecycle stage.
Based on its anti-schistosomula activity, 7-keto-sempervirol’s ability to affect adult schisto-
some motility, surface-tegument morphology and egg development was subsequently mea-
sured using both WHO-adopted indices and microscopic measures. Here, 7-keto-semperivol
Fig 1. 7-keto-sempervirol is a diterpenoid phenol derived from Lycium chinense. This compound
possesses a diterpenoid (C20) (4 isoprene units) scaffold consisting of a single phenyl group, one hydroxyl
group (red) and one carbonyl group (red). In light of Lipinski’s rule of 5 (RO5) [57], this compound only
possesses one violation to the rule (log p> 5), however, three out of the four core rules are satisfied.
doi:10.1371/journal.pntd.0003604.g001
Anthelmintic Activity of 7-Keto-Sempervirol
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displayed a significant effect on both male and female worm motility at the highest concentra-
tion used in this study (100 μM) at 24 hr and 48 hr post treatment compared to the DMSO
(24 hr) control group (Fig. 3). For both genders, there was no significant difference between
48 hr and 72 hr treatments at this concentration (Fig. 3) nor in DMSO treated worms cultivat-
ed for 48 hr or 72 hr (S2 Fig.). Interestingly, female worms (unlike males) displayed a 7-keto-
semperivol-induced hyperactivity at 24 hr post-treatment (Fig. 3). There were motility and
phenotypic discrepancies observed for some individuals cultured in the presence of 10 μM
7-keto-sempervirol, but these differences were not significantly different compared to the
Fig 2. The diterpenoid 7-keto-sempervirol displays lethal activity against Schistosomamansoni schistosomula. Schistosomula (96 well plate format;
1000 parasites/well; triplicate wells for each concentration assessed) were co-cultivated with a 50% dilution series of 7-keto-sempervirol (100, 50, 25, 12.5,
6.25, 3.125, 1.563 μM) at 37°C and 5%CO2 for 24 hr and subjected to the helminth fluorescent bioassay (HFB). A) Fluorescent data derived from wells were
converted into corresponding Log10 values and the mean percentage viability was transformed into probit values to create a dose-response curve as
previously described [25]. An LD50 of 19.1 μMwas calculated from this dose-response curve. Error bars represent the standard deviation of the mean (SD).
B) High content imaging of fluorescently labelled parasites (fluorescein diacetate, green and propidium iodide, red) co-cultured with titrated 7-keto-
sempervirol supports the HFBmeasurements. The concentration of fluorophores employed for high content imaging were the same as previously described
for the HFB [25]. Dead control = parasites co-cultured with 70 μM auranofin. DMSO control = parasites co-cultured with 1% (v/v) DMSO. Parasites were
imaged at 10 x magnification on a high content imaging system processed by the MetaXpress version 5.10.46 software utilising both FITC and TRITC filters.
doi:10.1371/journal.pntd.0003604.g002
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DMSO control group (S3 Fig.). Scanning electron microscopy (SEM) of adult male worms co-
cultured in the presence of 7-keto-sempervirol (100 μM for 72 hr) further revealed tubercle
swelling, spine loss/shortening and surface holes across the tegument (Fig. 4).
Laser scanning confocal microscopy (LSCM) of adult females cultured in the presence of
7-keto-sempervirol (100 μM for 24 hr) indicated the presence of irregularly shaped in utero eggs
(Fig. 5). When compared to control eggs (parasites treated with 1% v/v DMSO, Fig. 5A), these
abnormal eggs lacked regular autofluorescence as well as fully formed eggshells and were missing
the characteristic lateral spines indicative of the species (Fig. 5B). Due to these phenotypic defi-
ciencies in egg development, the effect that 7-keto-sempervirol had on in vitro schistosome ovi-
position was also assessed (Fig. 6). Here, 7-keto-sempervirol induced a concentration-dependent
(100 μM> 10 μM) ability to inhibit the deposition of phenotypically normal schistosome eggs
with a complete lack of oviposition observed in wells containing the highest amount of com-
pound (100 μM) (Fig. 6A). When compared to control wells (schistosomes co-cultured with 1%
v/v DMSO), eggs deposited in wells containing 7-keto-sempervirol (10 μM) displayed a range of
abnormal phenotypes (Fig. 6B) similar to those observed in utero (Fig. 5B). These phenotypes in-
cluded non-oval shapes, lack of lateral spines and irregular autofluorescence.
Anti-Fasciola 7-keto-sempervirol activities
To assess 7-keto-sempervirol’s activity on F. hepatica NEJs, two complementary methodologies
were employed (Fig. 7). The first methodology, using well-established motility and phenotypic
Fig 3. Adult Schistosomamansonimotility is reduced in the presence of 7-keto-sempervirol.World Health Organisation motility metrics were used for
scoring adult S.mansonimale and female worm phenotypes (5 worm pairs/ml) co-cultured (37°C and 5%CO2) with 7-keto-sempervirol (100 μM final
concentration) for 24 hr, 48 hr and 72 hr. Phenotypes derived from a control group (media containing 1% v/v DMSO) of male and female worms cultivated for
24 hr (worm pairs cultured for 48 hr or 72 hr were identical to the 24 hr worms, S2 Fig.) is also illustrated. Mean motility values are indicated as histograms (n
= 5 replicates/time-point) and the error bars represent the standard deviation of the mean (SD). Different letters indicate a significant difference between the
mean phenotypic scores calculated by ANOVA and Tukey’s post-hoc tests.
doi:10.1371/journal.pntd.0003604.g003
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metrics [31,32], indicated that 7-keto-sempervirol induced a negative concentration-dependent
effect on NEJ movement and viability (Fig. 7A). This finding was supported by fluorescent mi-
croscopy of NEJs co-stained with the discriminatory viability dyes FDA and PI (Fig. 7A). The
second methodology, using the HFB as a more objective method for determining NEJ viability
[25], confirmed this concentration-dependent effect and established an LD50 of 17.7 μM for
7-keto-sempervirol against F. hepatica NEJs (Fig. 7B). When compared to the mammalian
Fig 4. The diterpenoid 7-keto-sempervirol induces surface tegumental damage in adult Schistosoma
mansonimales. Scanning Electron Microscopic (SEM) images of adult S.mansonimale worms cultured for
72 hr at 37°C and 5%CO2 in the presence (100 μM) or absence (1% v/v DMSO) of 7-keto-sempervirol. A)
(left) 1.00K x magnification of a control (1% v/v DMSO) adult male surface (anterior end) and corresponding
(right) 6.00K x magnification of normal tubercles. B) (left) 1.00K x magnification of a 7-keto-sempervirol
treated (100 μM), adult male surface (anterior end) and enlarged (right) 9.00K x magnification of two indicated
(black boxes) areas of tegumental damage. Holes in the surface tegument/tubercles are indicated by white
arrows. These images are representative of 5 adult worms/condition.
doi:10.1371/journal.pntd.0003604.g004
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Fig 5. Schistosomamansoni egg-shell formation is inhibited by 7-keto-sempervirol. Adult S.mansoni
female worms were cultured (+/- 100 μM 7-keto-sempervirol) for 24 hr at 37°C and 5%CO2. A) 40x laser
scanning confocal microscopic image of an egg derived from a control female (1% v/v DMSO) demonstrating
regular auto-fluorescence and a well-formed lateral spine (normal architecture of a S.mansoni egg). B) 40x
laser scanning confocal microscopic image of an egg derived from one adult female worm treated with 100
μM 7-keto-sempervirol. Images are representative of typical in utero egg phenotypes obtained from 5 worms/
condition.
doi:10.1371/journal.pntd.0003604.g005
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Fig 6. Schistosomamansoni oviposition is inhibited by 7-keto-sempervirol. Adult worm pairs (5 pairs/
ml) were co-cultured (37 oC and 5%CO2) with 1% v/v DMSO (DMSO control), 10 μM 7-keto-sempervirol or
100 μM 7-keto-sempervirol for 72 hr. A) Bar charts represent the mean percentage of abnormal eggs (lacking
a fully formed lateral spine) produced after 72 hr (n = 5 replicates/treatment). Error bars represent the
standard deviation of the mean (SD). After 72 hr, a total of 68.4 +/- 74.4 eggs (normal and abnormal) were
enumerated in the worm cultures containing 1% DMSO, 73.2 +/- 46.4 eggs (normal and abnormal) were
observed in the cultures containing 10 μM 7-keto-sempervirol and zero eggs were counted in the wells
containing 100 μM 7-keto-sempervirol. Student’s t-test indicates that a significant difference exists between
the percentage of abnormal eggs laid between the 1% v/v DMSO and 10 μM 7-keto-sempervirol treatments
(p = 0.01). B) Fluorescent images of representative eggs deposited in vitro demonstrate normal egg
architecture in the DMSO control wells (DMSO control) and abnormal egg architecture in the 10 μM 7-keto-
sempervirol wells (7-keto-sempervirol).
doi:10.1371/journal.pntd.0003604.g006
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Fig 7. The diterpenoid 7-keto-sempervirol displays lethal activity against Fasciola hepatica newly
excysted juveniles (NEJs).Complementary phenotypic-based [31,32] and fluorescent-mediated tests [25]
were used to assess NEJ viability. A) The phenotypic assay involved co-culturing 20 NEJs (96-well plate
format) with a 50% dilution series of 7-keto-sempervirol (100, 50, 25, 12.5, 6.25, 3.125, 1.563 μM) at 37°C
and 5%CO2 for 24 hr. Mean phenotypic score values (11 = severely affected, 0 = not affected) are indicated
by bar charts (n = 20 individuals scored/experimental treatment) with error bars representing the standard
deviation of the mean (SD). A collection of fluorescent high content images (10 x) was obtained similar to
those collected for schistosomula (Fig. 2). B) The fluorescent assay utilised the HFB [25] and co-cultured 100
NEJs/experimental treatment (96-well plate format) with the same dilution series of 7-keto-sempervirol used
in the phenotypic-based test. Each concentration was converted into corresponding Log10 values and the
percentage viability was transformed into probit values to create a dose-response curve. An LD50 of 17.7 μM
was calculated from this dose-response curve. One representative HFB is illustrated here. Dead control =
NEJs co-cultured with 70 μM auranofin. DMSO control = NEJs co-cultured with 1% v/v DMSO.
doi:10.1371/journal.pntd.0003604.g007
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Fig 8. The diterpenoid 7-keto-sempervirol induces damage, shortening and loss of adult Fasciola
hepatica tegumental spines. SEM images of adult F. hepatica 48 hr post-treatment with culture media
containing DMSO (1% v/v) or 100 μM 7-keto-sempervirol. A) Normal fluke ventral surface architecture
including oral sucker (OS) and ventral sucker (VS) is unaffected after cultivation with culture media containing
1% (v/v) DMSO. B) Fluke dorsal surface architecture is also unaffected after cultivation with culture media
containing 1% (v/v) DMSO. C) Fluke ventral spine phenotype after cultivation with culture media containing
1% (v/v) DMSO. D) Dorsal spine sockets (ss) and folding (fo) after cultivation with 100 μM 7-keto-sempervirol.
E) Ventral spines after cultivation with 100 μM 7-keto-sempervirol. F) Higher magnification of (ss) region
outlined by black box in (D).
doi:10.1371/journal.pntd.0003604.g008
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HepG2 cell line (S1 Fig.), 7-keto-sempervirol displayed an anti-NEJ therapeutic index of 4.5.
To identify whether 7-keto-sempervirol also affected the surface integrity of F. hepatica adults,
similar to S.mansoni (Fig. 4), SEM analyses were performed on adult liver flukes co-cultured
with this diterpenoid (Fig. 8). Here, in comparison to control flukes incubated with 1% (v/v)
DMSO (Fig. 8A-C), prolonged (48 hr) exposure to 7-keto-sempervirol (50 μM) induced sub-
stantial spine shortening and spine loss that was apparent on both dorsal and ventral sides of
the organism (Fig. 8D-F).
Discussion
Current control efforts aimed at reducing disease prevalence of schistosomiasis and fascioliasis
are predominantly based on mono-chemotherapy administration of praziquantel (PZQ) and
triclabendazole (TCBZ), respectively. Nevertheless, worries about the development of PZQ re-
sistant blood flukes and the spread of TCBZ resistant liver flukes coupled to the slow progres-
sion of immunoprophylactic vaccines, have notably increased the number of new anthelmintic
drug discovery projects initiated throughout the last decade. While our efforts in this area have
successfully leveraged interdisciplinary techniques to identify drug targets [38–42] and to de-
velop high-throughput drug screening methodologies [25], we have only recently begun char-
acterising the detailed anthelmintic activities of defined chemical entities. Here, we report the
findings from one such investigation and demonstrate that a diterpenoid (7-keto-sempervirol)
derived from Lycium chinense has key properties useful in the development of a broad-
spectrum agent active against both blood and liver flukes.
First amongst the examined properties was the ability of 7-keto-sempervirol to kill, in a con-
centration dependent manner, both S.mansoni schistosomula (Fig. 2) and F. hepatica newly
excysted juveniles (NEJs) (Fig. 7) during in vitro culture. While this anti-larval effect was not
overly potent (LD50 = 17.7 μM for schistosomula and LD50 = 19.1 μM for NEJs), it was selective
(therapeutic index = 4.2–4.5) and reproducible (e.g. two independent measurements of NEJ vi-
ability provided confirmatory results, Fig. 7). Importantly, this moderate anti-larval effect
translated into pronounced phenotypic abnormalities associated with the tegumental surface
of both fluke species (Figs. 4 and 8). Here, and similar to artemisinin’s effect on S.mansoni [7]
and artemether/artesunate’s effect on F. hepatica [43], 7-keto-sempervirol induced tubercle
swelling, tegumental breaches and spine loss in both flukes. This degree of surface damage
(also seen in [9,33,44]), if replicated in vivo, would severely compromise the barrier function of
this protective layer [45] and negatively affect the ability of both flukes to remain in hostile de-
finitive host environments (blood and bile). Whether 7-keto-sempervirol’s ability to disrupt
fluke surface architecture is similar in action to the protonophoric properties of membrane-
disruptive, plant-derived quinones (anti-tumour derived diterpenoids) [46] is currently un-
known, but is consistent with our observations. Further work is required to develop this line
of investigation.
Another interesting property of 7-keto-sempervirol is its ability to progressively paralyse
adult schistosomes during in vitro culture (Fig. 3). This feature, in addition to tegumental alter-
ations, is similar to the effects induced by praziquantel [47] treatment of adult schistosomes
and suggests that this diterpenoid may also perturb calcium homeostasis [3]. Interestingly, the
antifungal activities of two related mono-terpenoid phenols (carvacrol and thymol) also in-
volve dis-regulation of intracellular calcium balances and suggest a common mechanism of ac-
tion amongst terpenes [48] and praziquantel. In support of this, treatment of Saccharomyces
cerevisiae with either carvacrol or thymol leads to the differential expression of similar gene
categories as those found in praziquantel treated schistosomes [47]. These include genes associ-
ated with drug transportation across membranes, ribosomal biogenesis, autophagy, heat shock
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responses, rRNA processing, tRNA processing and pyrimidine metabolism [48]. Whether
7-keto-sempervirol is capable of differentially regulating a similar repertoire of schistosome
gene products is currently unknown, but the time-dependent paralysis of adults co-cultured
with this diterpenoid in vitro would suggest that this hypothesis is likely. Gender specific tran-
scriptomic responses to 7-keto-sempervirol may also exist, similar to those induced by prazi-
quantel [47], and could explain the differential sensitivity and hyperactivity observed in
females (but not males) at 24 hr post treatment (Fig. 3). While 7-keto-sempervirol/adult
F. hepatica co-cultures were not kinetically studied in this investigation, it would be useful to
ascertain in future experiments if the diterpenoid-induced, time-dependent paralysis of dioe-
cious blood flukes translates to hermaphroditic liver flukes.
A final anthelmintic property examined for 7-keto-sempervirol, based on its established ca-
pacity to damage surface membranes (Figs. 4 & 8) and impede schistosome motility (Fig. 3),
was its potential to affect egg production during in vitro cultures (Figs. 5 & 6). As oviposition is
required for schistosome lifecycle transmission and is responsible for chronic definitive host
immunopathology, identification and progression of compounds that inhibit this process
(even if they do not kill the parasite) are likely to benefit schistosomiasis control. Interestingly,
the concentration-dependent (100 μM> 10 μM), 7-keto-sempervirol mediated, inhibition of
phenotypically-normal egg maturation (Fig. 5 & 6B) and egg production (Fig. 6A) observed
here are strikingly similar to those findings reported for schistosome pairs co-cultured with
kojic acid [41]. Kojic acid exerts its effects on eggshell sclerotisation (hardening or tanning)
and schistosome oviposition by inhibiting the phenol oxidase activities of S.mansoni tyrosi-
nases 1 and 2 (SmTYR1/SmTYR2). Whether 7-keto-sempervirol also targets the phenol oxi-
dase activity of SmTYR1/SmTYR2 is currently unknown. However, as egg maturation,
sclerotisation and oviposition are complex processes involving cytosine methylation [40], tyro-
sine kinase-mediated phosphorylation [49] serine/threonine kinase-mediated phosphorylation
[50], fatty acid oxidation [51] and TGF-beta signalling [52], 7-keto-sempervirol could theoreti-
cally act upon any component of these (or other) diverse biological processes. Limitations in
obtaining sufficient quantities of adult F. hepatica prohibited the assessment of 7-keto-semper-
virol’s effect on liver fluke egg production. Nevertheless, as the process of eggshell formation is
thought to occur via similar mechanisms in both schistosomes and liver flukes [53], it is likely
that 7-keto-sempervirol will also inhibit F. hepatica oviposition.
Here, we provide complementary evidence that supports the further progression of 7-keto-
sempervirol as a dual anthelmintic against S.mansoni and F. hepatica parasites. Although
these findings add value to the growing medicinal properties described for diterpenoids
[54–56] and expand upon their anti-schistosomal chemoprophylactic characteristics [21,22],
improving their selective potency is a necessary next step in their development as wide-acting
anthelmintics. Whilst defining a specific mechanism of 7-keto-sempervirol action and experi-
mental animal model verification was beyond the scope of this investigation, our results suggest
that membrane biogenesis/maintenance and calcium homeostasis/stress are likely contributing
to the diverse in vitro phenotypes observed in both fluke species. Activity against both larvae
and adult fluke stages broaden the window of therapeutic opportunity and, if replicable in vivo,
would provide a useful alternative to currently used anthelmintics within the biomedical and
animal health landscapes.
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